# CPG 7909 Injection in Non-Small Cell Lung Cancer

> **NCT00070629** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 116 (actual)

## Conditions studied

- Carcinoma, Non-Small Cell Lung

## Interventions

- **DRUG:** CPG 7909
- **DRUG:** Chemotherapy
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT00070629
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2009-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00070629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00070629, "CPG 7909 Injection in Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00070629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*